COVID-19 Impact on Global Alpha Thalassemia Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 92 pages | ID: C90EC1E416B9EN
QYResearch

Abstracts

This report focuses on the global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• GlaxoSmithKline
• Novartis AG
• Bellicum Pharmaceuticals
• Acceleron Pharma
• Johnson & Johnson
• Merck & Co.
• Gilead Sciences, Inc.

Market segment by Type, the product can be split into

• Folic Acid
• Deferasirox
• Deferiprone
• Hydroxyurea

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Alpha Thalassemia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Alpha Thalassemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alpha Thalassemia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alpha Thalassemia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Folic Acid
  1.4.3 Deferasirox
  1.4.4 Deferiprone
  1.4.5 Hydroxyurea
1.5 Market by Application
  1.5.1 Global Alpha Thalassemia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Alpha Thalassemia Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Alpha Thalassemia Treatment Industry
    1.6.1.1 Alpha Thalassemia Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Alpha Thalassemia Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Alpha Thalassemia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Alpha Thalassemia Treatment Market Perspective (2015-2026)
2.2 Alpha Thalassemia Treatment Growth Trends by Regions
  2.2.1 Alpha Thalassemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alpha Thalassemia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Alpha Thalassemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alpha Thalassemia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Alpha Thalassemia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alpha Thalassemia Treatment Players by Market Size
  3.1.1 Global Top Alpha Thalassemia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alpha Thalassemia Treatment Market Concentration Ratio
  3.2.1 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Treatment Revenue in 2019
3.3 Alpha Thalassemia Treatment Key Players Head office and Area Served
3.4 Key Players Alpha Thalassemia Treatment Product Solution and Service
3.5 Date of Enter into Alpha Thalassemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Alpha Thalassemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Type (2021-2026)

5 ALPHA THALASSEMIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Alpha Thalassemia Treatment Market Size by Application (2015-2020)
5.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alpha Thalassemia Treatment Market Size (2015-2020)
6.2 Alpha Thalassemia Treatment Key Players in North America (2019-2020)
6.3 North America Alpha Thalassemia Treatment Market Size by Type (2015-2020)
6.4 North America Alpha Thalassemia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alpha Thalassemia Treatment Market Size (2015-2020)
7.2 Alpha Thalassemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Alpha Thalassemia Treatment Market Size by Type (2015-2020)
7.4 Europe Alpha Thalassemia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Alpha Thalassemia Treatment Market Size (2015-2020)
8.2 Alpha Thalassemia Treatment Key Players in China (2019-2020)
8.3 China Alpha Thalassemia Treatment Market Size by Type (2015-2020)
8.4 China Alpha Thalassemia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alpha Thalassemia Treatment Market Size (2015-2020)
9.2 Alpha Thalassemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Alpha Thalassemia Treatment Market Size by Type (2015-2020)
9.4 Japan Alpha Thalassemia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alpha Thalassemia Treatment Market Size (2015-2020)
10.2 Alpha Thalassemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alpha Thalassemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Alpha Thalassemia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Alpha Thalassemia Treatment Market Size (2015-2020)
11.2 Alpha Thalassemia Treatment Key Players in India (2019-2020)
11.3 India Alpha Thalassemia Treatment Market Size by Type (2015-2020)
11.4 India Alpha Thalassemia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alpha Thalassemia Treatment Market Size (2015-2020)
12.2 Alpha Thalassemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Alpha Thalassemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Alpha Thalassemia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Introduction
  13.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Novartis AG
  13.2.1 Novartis AG Company Details
  13.2.2 Novartis AG Business Overview and Its Total Revenue
  13.2.3 Novartis AG Alpha Thalassemia Treatment Introduction
  13.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.2.5 Novartis AG Recent Development
13.3 Bellicum Pharmaceuticals
  13.3.1 Bellicum Pharmaceuticals Company Details
  13.3.2 Bellicum Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Introduction
  13.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.3.5 Bellicum Pharmaceuticals Recent Development
13.4 Acceleron Pharma
  13.4.1 Acceleron Pharma Company Details
  13.4.2 Acceleron Pharma Business Overview and Its Total Revenue
  13.4.3 Acceleron Pharma Alpha Thalassemia Treatment Introduction
  13.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.4.5 Acceleron Pharma Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson Alpha Thalassemia Treatment Introduction
  13.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 Merck & Co.
  13.6.1 Merck & Co. Company Details
  13.6.2 Merck & Co. Business Overview and Its Total Revenue
  13.6.3 Merck & Co. Alpha Thalassemia Treatment Introduction
  13.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.6.5 Merck & Co. Recent Development
13.7 Gilead Sciences, Inc.
  13.7.1 Gilead Sciences, Inc. Company Details
  13.7.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  13.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Introduction
  13.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2015-2020)
  13.7.5 Gilead Sciences, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Alpha Thalassemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Alpha Thalassemia Treatment Revenue
Table 3. Ranking of Global Top Alpha Thalassemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alpha Thalassemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Folic Acid
Table 6. Key Players of Deferasirox
Table 7. Key Players of Deferiprone
Table 8. Key Players of Hydroxyurea
Table 9. COVID-19 Impact Global Market: (Four Alpha Thalassemia Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Alpha Thalassemia Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Alpha Thalassemia Treatment Players to Combat Covid-19 Impact
Table 14. Global Alpha Thalassemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Alpha Thalassemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Alpha Thalassemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Alpha Thalassemia Treatment Market Share by Regions (2015-2020)
Table 18. Global Alpha Thalassemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Alpha Thalassemia Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Alpha Thalassemia Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Alpha Thalassemia Treatment Players
Table 25. Global Alpha Thalassemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Alpha Thalassemia Treatment Market Share by Players (2015-2020)
Table 27. Global Top Alpha Thalassemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia Treatment as of 2019)
Table 28. Global Alpha Thalassemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Alpha Thalassemia Treatment Product Solution and Service
Table 31. Date of Enter into Alpha Thalassemia Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Alpha Thalassemia Treatment Market Size Share by Type (2015-2020)
Table 35. Global Alpha Thalassemia Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Alpha Thalassemia Treatment Market Size Share by Application (2015-2020)
Table 37. Global Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Alpha Thalassemia Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 41. North America Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 43. North America Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 47. Europe Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 49. Europe Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 53. China Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 55. China Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 59. Japan Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 61. Japan Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 65. Southeast Asia Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 71. India Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 73. India Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Alpha Thalassemia Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Alpha Thalassemia Treatment Market Share (2019-2020)
Table 77. Central & South America Alpha Thalassemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Alpha Thalassemia Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Alpha Thalassemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Alpha Thalassemia Treatment Market Share by Application (2015-2020)
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 85. GlaxoSmithKline Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Product
Table 89. Novartis AG Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 90. Novartis AG Recent Development
Table 91. Bellicum Pharmaceuticals Company Details
Table 92. Bellicum Pharmaceuticals Business Overview
Table 93. Bellicum Pharmaceuticals Product
Table 94. Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 95. Bellicum Pharmaceuticals Recent Development
Table 96. Acceleron Pharma Company Details
Table 97. Acceleron Pharma Business Overview
Table 98. Acceleron Pharma Product
Table 99. Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 100. Acceleron Pharma Recent Development
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 105. Johnson & Johnson Recent Development
Table 106. Merck & Co. Company Details
Table 107. Merck & Co. Business Overview
Table 108. Merck & Co. Product
Table 109. Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 110. Merck & Co. Recent Development
Table 111. Gilead Sciences, Inc. Company Details
Table 112. Gilead Sciences, Inc. Business Overview
Table 113. Gilead Sciences, Inc. Product
Table 114. Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2015-2020) (Million US$)
Table 115. Gilead Sciences, Inc. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Alpha Thalassemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Folic Acid Features
Figure 3. Deferasirox Features
Figure 4. Deferiprone Features
Figure 5. Hydroxyurea Features
Figure 6. Global Alpha Thalassemia Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Alpha Thalassemia Treatment Report Years Considered
Figure 11. Global Alpha Thalassemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Alpha Thalassemia Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Alpha Thalassemia Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Alpha Thalassemia Treatment Market Share by Players in 2019
Figure 16. Global Top Alpha Thalassemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Alpha Thalassemia Treatment Revenue in 2019
Figure 18. North America Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Alpha Thalassemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GlaxoSmithKline Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 27. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis AG Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 29. Bellicum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bellicum Pharmaceuticals Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 31. Acceleron Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 33. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Johnson & Johnson Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 35. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Merck & Co. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 37. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Gilead Sciences, Inc. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed